Any cases in Australia yet ?

Banji Sanni Mary Sanni

I am glad that James never got the 2nd shot, the 1st shot did enough damage. The sad part is that we are fighting a brick wall with no help. He suffered a side effect LISTED on the package, and was available to the relevant HSE personnel. Yet, we got nowhere. And they drag it on because the statute of limitations is running out and has run out for many. All vaccine damages are treated with the same term -idiopathic and physcological by the Irish Government, who don't give a damn. We are left to try and manage by ourselves.

I even discovered that symptoms I had e.g. nightmares were part of the side effects from the vaccine. I just thought they were a random unrelated thing. It makes you wonder how many other symptoms you have are linked to it and not just coincidental 🤔😳

John Hunt

I'll look at that later jess but not surprised. I think you should focus on Rob & kids theyr the ones who matter. Had great day not long dun dinner. Xx

There is no pandemic threat. They make it up for sales tactics. This is what we have now. Same goes for in Ireland. If you look at real historic data it shows disease was declining dramatically before the introduction of mass vaccinations. Here is a great article with links to real facts. jbhandleyblog.com/home/2018/5/14/savehumanity

Inspiring story what a wonderful girl and amazing boyfriend

en.wikipedia.org/wiki/Encephalomyelitis

Dear Mrs. Sullivan, Thank you for your emails of the 10th and 15th April 2014. Your comments are noted and we will add this updated information to the existing record of your son’s condition. As you have stated nervous system disorders such as encephalomyelitis are a known side effect associated with Pandemrix. Details of such effects are included in the approved product information (Summary of Product Characteristics (SmPC) section 4.8) for Pandemrix, previously provided and publically available, so as such will be known to relevant HSE personnel. Kindest regards, Emma Emma Mooney BSc. MSc. Scientific Officer - Pharmacovigilance Human Products Monitoring Department Irish Medicines Board | Bord Leigheasra na hÉireann Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2. Tel: +353 1 676 4971 Fax: +353 1 676 2517

Copied and pasted from an email last year. QUESTION NO: 636 DÁIL QUESTION addressed to the Minister for Health (Dr. James Reilly) by Deputy Caoimhghín Ó Caoláin for WRITTEN ANSWER on 21/01/2014 * To ask the Minister for Health if he will provide the list of all side effects of the swineflu vaccine Pandemrix reported to the Health Service Executive since 2010, both including and excluding Narcolepsy; the numbers of reported incidents of these side effects also including and excluding Narcolepsy; and if he will make a statement on the matter. Caoimhghín Ó Caoláin T.D. REPLY. The competent authority for licensing and safety of all medicines, including vaccines licensed in Ireland is the Irish Medicines Board (IMB). From 2010 to date, the IMB has received 783 reports of suspected adverse reactions to Pandemrix, the majority of which are consistent with the known effects of the vaccine as described in the product information (product information for all authorised products is publically accessible via the IMB website). The most frequently reported reactions included the following : 754 - Nervous system disorders including dizziness, headache, fainting, and drowsiness; 485 - General disorders including fatigue, injection site reactions, temperature changes and weakness; 259 - Gastrointestinal disorders including nausea, vomiting, diarrhoea and abdominal pain; 127 - Skin and hypersensitivity disorders including rash and allergic type effects; 121 - Musculoskeletal disorders including muscle pain and muscle weakness. Many of the reports describe a number of reactions, so the number of reactions exceeds the number of reports. To date, the IMB has received reports of 49 cases with clinical information confirming a diagnosis of narcolepsy in relation to individuals vaccinated with Pandemrix. However the IMB is awaiting information on further possible cases where clinical investigations are ongoing and is actively following up to obtain this information. Overall updates on national adverse reaction reporting experience are shared with relevant HSE groups, including the Health Protection Surveillance Centre, the National Immunisation Office and with representatives of the Department of Health through the National Immunisation Advisory Committee (NIAC), at which all of the relevant groups are represented. Reply, Reply all or Forward